Share Price and Basic Stock Data
Last Updated: December 14, 2024, 10:13 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Alchemist Ltd operates in an unspecified industry, with its stock currently priced at ₹3.01 and a market capitalization of ₹4.08 Cr. The company reported sales of ₹6 lakh for the trailing twelve months (TTM), a significant decline from ₹1,457 Cr in March 2013. This downward trend in revenue is starkly evident, as sales fell from ₹886 Cr in March 2012 to just ₹14 Cr by March 2020. The most alarming drop occurred between March 2019 and March 2020, where sales plummeted from ₹27 Cr to ₹14 Cr. This decline indicates severe challenges in generating revenue, potentially due to operational inefficiencies or market conditions. Over the years, operating profit margins (OPM) have also deteriorated drastically, recording a staggering -31,800% in the last reported quarter. Such metrics suggest that Alchemist Ltd faces significant hurdles in maintaining revenue generation amidst mounting operational losses.
Profitability and Efficiency Metrics
Alchemist Ltd’s profitability metrics highlight a troubling financial situation. Net profit for the TTM stood at -₹228 Cr, following a pattern of losses that have plagued the company since at least March 2015, when it recorded a loss of ₹38 Cr. The company’s interest coverage ratio (ICR) was reported at -91.90x, indicating that it is struggling to meet its interest obligations, which is a severe red flag for creditors and investors alike. Furthermore, the return on capital employed (ROCE) has deteriorated to -10%, reflecting inefficiency in utilizing capital for generating returns. The cash conversion cycle (CCC) extended to an alarming 4,723 days, indicating severe liquidity issues and inefficiencies in managing working capital. Such metrics not only reveal the company’s dire profitability but also raise concerns about its operational efficiency, potentially jeopardizing its long-term viability.
Balance Sheet Strength and Financial Ratios
The balance sheet of Alchemist Ltd presents a concerning picture, particularly with a reported reserve deficit of -₹397 Cr and borrowings of ₹764 Cr as of the latest quarter. This results in a troubling debt-to-equity ratio that signals financial distress, with total liabilities exceeding total assets, which stood at ₹422 Cr. The company’s book value per share was reported at -₹144.68, emphasizing that shareholders’ equity is effectively wiped out. Moreover, the price-to-book value ratio of -0.01x suggests that the stock is trading well below its intrinsic value, reflecting investor pessimism. The current ratio of 2.43x indicates that the company has enough short-term assets to cover its short-term liabilities, but the overall financial ratios suggest a precarious financial position that may deter potential investors and creditors.
Shareholding Pattern and Investor Confidence
As of the latest reporting, Alchemist Ltd’s shareholding pattern shows that promoters hold 34.94% of the company, while public shareholding constitutes 63.54%. The presence of institutional investors is minimal, with foreign institutional investors (FIIs) holding 0% and domestic institutional investors (DIIs) at 1.51%. The number of shareholders has increased to 10,223, indicating a slight rise in public interest, despite the company’s financial struggles. This distribution reflects a lack of confidence from institutional investors, likely due to the company’s financial instability and declining performance. The sharp decline in FII participation from 9.75% in December 2017 to 0% by March 2020 further underscores the challenges in maintaining investor confidence. The high public shareholding could be viewed as a double-edged sword; while it reflects retail interest, it also indicates a lack of institutional backing, often seen as a vote of confidence in a company’s prospects.
Outlook, Risks, and Final Insight
Alchemist Ltd faces significant risks moving forward, primarily stemming from its ongoing operational inefficiencies and mounting debt levels. The persistent losses and negative profitability metrics raise questions about the company’s ability to sustain operations without substantial restructuring or capital infusion. Furthermore, the high cash conversion cycle of 4,723 days poses a liquidity risk, making it difficult to meet short-term obligations. On the other hand, potential strengths include its substantial public shareholding and the ability to manage short-term liabilities as indicated by its current ratio. The company could explore strategic partnerships or operational restructuring to improve its financial health. In scenarios where operational efficiencies are realized, there could be a turnaround in profitability; conversely, failure to address these issues may lead to further declines in market confidence and financial viability.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Alchemist Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 125 Cr. | 32.1 | 869/31.8 | 1.22 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 2,533 Cr. | 187 | 227/124 | 101 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 55.2 Cr. | 4.33 | 8.90/3.97 | 5.12 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,853.48 Cr | 262.95 | 344.63 | 101.24 | 0.22% | 11.73% | 22.92% | 9.18 |
Quarterly Result
| Metric | Dec 2012 | Mar 2013 | Jun 2013 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 388 | 360 | 409 | 9 | 6 | 6 | 6 | 6 | 5 | 3 | 1 | 1 | 1 |
| Expenses | 375 | 352 | 398 | -9 | 73 | 8 | 8 | 7 | 5 | 4 | 49 | 1 | 373 |
| Operating Profit | 12 | 8 | 11 | 18 | -67 | -2 | -2 | -1 | -1 | -1 | -48 | 0 | -372 |
| OPM % | 3% | 2% | 3% | 204% | -1,116% | -25% | -43% | -16% | -14% | -52% | -3,731% | 5% | -31,800% |
| Other Income | 4 | 8 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 124 |
| Interest | 2 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 3 | 4 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 12 | 9 | 8 | 16 | -69 | -3 | -4 | -3 | -2 | -3 | -50 | -1 | -250 |
| Tax % | 11% | 61% | 30% | -1% | 1% | 10% | -271% | 7% | 8% | -54% | -20% | 12% | -26% |
| Net Profit | 10 | 4 | 5 | 16 | -70 | -3 | 7 | -3 | -3 | -1 | -40 | -2 | -186 |
| EPS in Rs | 7.54 | 2.70 | 3.95 | 11.59 | -51.46 | -2.22 | 5.48 | -2.16 | -1.89 | -1.08 | -29.33 | -1.15 | -136.88 |
Last Updated: Unknown
Below is a detailed analysis of the quarterly data for Alchemist Ltd based on the most recent figures (Sep 2020) and their trends compared to the previous period:
- For Sales, as of Sep 2020, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2020) which recorded 1.00 Cr..
- For Expenses, as of Sep 2020, the value is 373.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Jun 2020) to 373.00 Cr., marking an increase of 372.00 Cr..
- For Operating Profit, as of Sep 2020, the value is -372.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.00 Cr. (Jun 2020) to -372.00 Cr., marking a decrease of 372.00 Cr..
- For OPM %, as of Sep 2020, the value is -31,800.00%. The value appears to be declining and may need further review. It has decreased from 5.00% (Jun 2020) to -31,800.00%, marking a decrease of 31,805.00%.
- For Other Income, as of Sep 2020, the value is 124.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Jun 2020) to 124.00 Cr., marking an increase of 124.00 Cr..
- For Interest, as of Sep 2020, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2020) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2020, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2020) which recorded 2.00 Cr..
- For Profit before tax, as of Sep 2020, the value is -250.00 Cr.. The value appears to be declining and may need further review. It has decreased from -1.00 Cr. (Jun 2020) to -250.00 Cr., marking a decrease of 249.00 Cr..
- For Tax %, as of Sep 2020, the value is -26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 12.00% (Jun 2020) to -26.00%, marking a decrease of 38.00%.
- For Net Profit, as of Sep 2020, the value is -186.00 Cr.. The value appears to be declining and may need further review. It has decreased from -2.00 Cr. (Jun 2020) to -186.00 Cr., marking a decrease of 184.00 Cr..
- For EPS in Rs, as of Sep 2020, the value is -136.88. The value appears to be declining and may need further review. It has decreased from -1.15 (Jun 2020) to -136.88, marking a decrease of 135.73.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 7, 2025, 9:20 pm
| Metric | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 386 | 396 | 503 | 886 | 1,457 | 1,508 | 350 | 105 | 24 | 27 | 27 | 14 | 6 |
| Expenses | 355 | 364 | 468 | 852 | 1,417 | 1,475 | 375 | 138 | 53 | 36 | 80 | 65 | 427 |
| Operating Profit | 32 | 32 | 35 | 34 | 41 | 33 | -26 | -33 | -29 | -10 | -53 | -51 | -422 |
| OPM % | 8% | 8% | 7% | 4% | 3% | 2% | -7% | -32% | -121% | -36% | -199% | -354% | -7,096% |
| Other Income | 3 | 3 | 1 | 12 | 16 | 14 | 14 | 13 | -69 | 3 | 1 | 0 | 124 |
| Interest | 8 | 7 | 4 | 4 | 7 | 4 | 5 | 5 | 2 | 2 | 1 | 1 | 0 |
| Depreciation | 8 | 8 | 10 | 11 | 12 | 15 | 23 | 26 | 8 | 8 | 7 | 7 | 6 |
| Profit before tax | 19 | 20 | 22 | 31 | 38 | 28 | -39 | -52 | -108 | -16 | -61 | -58 | -304 |
| Tax % | 28% | 22% | 40% | 23% | 25% | 55% | -2% | 3% | -1% | 3% | -18% | -19% | |
| Net Profit | 14 | 16 | 13 | 24 | 27 | 12 | -38 | -53 | -107 | -17 | -50 | -47 | -228 |
| EPS in Rs | 11.50 | 12.91 | 10.68 | 18.54 | 20.05 | 10.44 | -26.36 | -35.67 | -79.15 | -12.47 | -36.61 | -34.46 | -168.44 |
| Dividend Payout % | 17% | 16% | 19% | 22% | 7% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2009-2010 | 2010-2011 | 2011-2012 | 2012-2013 | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 14.29% | -18.75% | 84.62% | 12.50% | -55.56% | -416.67% | -39.47% | -101.89% | 84.11% | -194.12% | 6.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -33.04% | 103.37% | -72.12% | -68.06% | -361.11% | 377.19% | -62.41% | 186.00% | -278.23% | 200.12% |
Alchemist Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2009-2010 to 2019-2020.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -28% |
| 5 Years: | -47% |
| 3 Years: | -16% |
| TTM: | -74% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -12% |
| 3 Years: | -9% |
| TTM: | -21246% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -18% |
| 5 Years: | -12% |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 4, 2025, 10:40 pm
Balance Sheet
Last Updated: October 10, 2025, 1:35 pm
| Month | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 13 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 94 | 103 | 81 | 78 | 151 | 122 | 73 | 21 | -97 | -113 | -163 | -210 | -397 |
| Borrowings | 151 | 157 | 216 | 342 | 322 | 789 | 721 | 738 | 740 | 752 | 763 | 768 | 764 |
| Other Liabilities | 51 | 55 | 85 | 80 | 79 | 233 | 222 | 226 | 178 | 170 | 161 | 161 | 42 |
| Total Liabilities | 308 | 327 | 394 | 512 | 566 | 1,159 | 1,030 | 999 | 835 | 822 | 774 | 733 | 422 |
| Fixed Assets | 162 | 173 | 193 | 200 | 235 | 276 | 433 | 405 | 162 | 154 | 147 | 140 | 137 |
| CWIP | 40 | 45 | 74 | 135 | 201 | 202 | 27 | 19 | -0 | -0 | -0 | -0 | -0 |
| Investments | 24 | 24 | 23 | 2 | 2 | 2 | 2 | 2 | 171 | 169 | 169 | 169 | 169 |
| Other Assets | 82 | 85 | 104 | 176 | 128 | 679 | 568 | 574 | 503 | 500 | 459 | 424 | 116 |
| Total Assets | 308 | 327 | 394 | 512 | 566 | 1,159 | 1,030 | 999 | 835 | 822 | 774 | 733 | 422 |
Below is a detailed analysis of the balance sheet data for Alchemist Ltd based on the most recent figures (Sep 2020) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2020, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2020) which recorded 14.00 Cr..
- For Reserves, as of Sep 2020, the value is -397.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -210.00 Cr. (Mar 2020) to -397.00 Cr., marking a decline of 187.00 Cr..
- For Borrowings, as of Sep 2020, the value is 764.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 768.00 Cr. (Mar 2020) to 764.00 Cr., marking a decrease of 4.00 Cr..
- For Other Liabilities, as of Sep 2020, the value is 42.00 Cr.. The value appears to be improving (decreasing). It has decreased from 161.00 Cr. (Mar 2020) to 42.00 Cr., marking a decrease of 119.00 Cr..
- For Total Liabilities, as of Sep 2020, the value is 422.00 Cr.. The value appears to be improving (decreasing). It has decreased from 733.00 Cr. (Mar 2020) to 422.00 Cr., marking a decrease of 311.00 Cr..
- For Fixed Assets, as of Sep 2020, the value is 137.00 Cr.. The value appears to be declining and may need further review. It has decreased from 140.00 Cr. (Mar 2020) to 137.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Sep 2020, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2020) which recorded 0.00 Cr..
- For Investments, as of Sep 2020, the value is 169.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2020) which recorded 169.00 Cr..
- For Other Assets, as of Sep 2020, the value is 116.00 Cr.. The value appears to be declining and may need further review. It has decreased from 424.00 Cr. (Mar 2020) to 116.00 Cr., marking a decrease of 308.00 Cr..
- For Total Assets, as of Sep 2020, the value is 422.00 Cr.. The value appears to be declining and may need further review. It has decreased from 733.00 Cr. (Mar 2020) to 422.00 Cr., marking a decrease of 311.00 Cr..
However, the Borrowings (764.00 Cr.) are higher than the Reserves (-397.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -119.00 | -125.00 | -181.00 | -308.00 | -281.00 | -756.00 | -747.00 | -771.00 | -769.00 | -762.00 | -816.00 | -819.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 16 | 16 | 15 | 11 | 4 | 99 | 495 | 1,732 | 7,098 | 6,471 | 5,807 | 9,597 |
| Inventory Days | 26 | 32 | 31 | 17 | 11 | 12 | 56 | 230 | 114 | 36 | 19 | 20 |
| Days Payable | 17 | 21 | 10 | 4 | 2 | 38 | 176 | 828 | 2,641 | 2,554 | 2,430 | 4,894 |
| Cash Conversion Cycle | 25 | 27 | 36 | 25 | 12 | 73 | 375 | 1,134 | 4,572 | 3,952 | 3,397 | 4,723 |
| Working Capital Days | 14 | 16 | -16 | -4 | 5 | 67 | 358 | 1,224 | 4,735 | 4,355 | 3,702 | 5,772 |
| ROCE % | 11% | 10% | 9% | 9% | 10% | 5% | -3% | -5% | -5% | -2% | -9% | -10% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -34.46 | -36.61 | -12.40 | -79.15 | -35.67 |
| Diluted EPS (Rs.) | -34.46 | -36.61 | -12.40 | -79.15 | -35.67 |
| Cash EPS (Rs.) | -29.56 | -31.52 | -6.75 | -73.28 | -19.90 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -144.68 | -110.27 | -73.55 | -61.33 | 32.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -144.68 | -110.27 | -73.55 | -61.33 | 32.55 |
| Revenue From Operations / Share (Rs.) | 10.63 | 19.72 | 19.62 | 17.82 | 77.47 |
| PBDIT / Share (Rs.) | -37.45 | -38.59 | -5.70 | -19.41 | -8.26 |
| PBIT / Share (Rs.) | -42.35 | -43.68 | -11.42 | -25.28 | -27.61 |
| PBT / Share (Rs.) | -42.76 | -44.69 | -12.16 | -80.00 | -38.02 |
| Net Profit / Share (Rs.) | -34.46 | -36.61 | -12.47 | -79.15 | -39.25 |
| NP After MI And SOA / Share (Rs.) | -34.46 | -36.61 | -12.47 | -79.15 | -35.67 |
| PBDIT Margin (%) | -352.38 | -195.73 | -29.03 | -108.90 | -10.66 |
| PBIT Margin (%) | -398.50 | -221.54 | -58.21 | -141.84 | -35.63 |
| PBT Margin (%) | -402.34 | -226.66 | -61.99 | -448.92 | -49.08 |
| Net Profit Margin (%) | -324.24 | -185.66 | -63.57 | -444.13 | -50.66 |
| NP After MI And SOA Margin (%) | -324.24 | -185.67 | -63.57 | -444.11 | -46.04 |
| Return on Networth / Equity (%) | 0.00 | 0.00 | 0.00 | 0.00 | -140.30 |
| Return on Capital Employeed (%) | -10.05 | -9.71 | -2.35 | -5.16 | -4.66 |
| Return On Assets (%) | -6.37 | -6.41 | -2.05 | -12.85 | -4.84 |
| Long Term Debt / Equity (X) | -3.89 | -5.05 | -7.46 | -8.83 | 20.86 |
| Total Debt / Equity (X) | -3.91 | -5.07 | -7.50 | -8.88 | 21.20 |
| Asset Turnover Ratio (%) | 0.01 | 0.03 | 0.03 | 0.02 | 0.01 |
| Current Ratio (X) | 2.43 | 2.66 | 2.93 | 2.85 | 2.82 |
| Quick Ratio (X) | 2.42 | 2.66 | 2.92 | 2.81 | 2.61 |
| Inventory Turnover Ratio (X) | 5.98 | 5.87 | 1.31 | 0.19 | 0.30 |
| Interest Coverage Ratio (X) | -91.90 | -38.22 | -4.50 | -11.66 | -2.23 |
| Interest Coverage Ratio (Post Tax) (X) | -83.56 | -35.26 | -9.27 | -14.68 | -7.79 |
| Enterprise Value (Cr.) | 765.56 | 759.40 | 757.00 | 766.59 | 762.63 |
| EV / Net Operating Revenue (X) | 53.12 | 28.40 | 28.46 | 31.72 | 7.26 |
| EV / EBITDA (X) | -15.07 | -14.51 | -98.01 | -29.13 | -68.09 |
| MarketCap / Net Operating Revenue (X) | 0.09 | 0.09 | 0.41 | 1.30 | 0.25 |
| Price / BV (X) | -0.01 | -0.01 | -0.11 | -0.37 | 0.78 |
| Price / Net Operating Revenue (X) | 0.09 | 0.09 | 0.41 | 1.30 | 0.25 |
| EarningsYield | -35.90 | -19.07 | -1.53 | -3.42 | -1.78 |
After reviewing the key financial ratios for Alchemist Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 20, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 19) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 20, the value is -34.46. This value is below the healthy minimum of 5. It has increased from -36.61 (Mar 19) to -34.46, marking an increase of 2.15.
- For Diluted EPS (Rs.), as of Mar 20, the value is -34.46. This value is below the healthy minimum of 5. It has increased from -36.61 (Mar 19) to -34.46, marking an increase of 2.15.
- For Cash EPS (Rs.), as of Mar 20, the value is -29.56. This value is below the healthy minimum of 3. It has increased from -31.52 (Mar 19) to -29.56, marking an increase of 1.96.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 20, the value is -144.68. It has decreased from -110.27 (Mar 19) to -144.68, marking a decrease of 34.41.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 20, the value is -144.68. It has decreased from -110.27 (Mar 19) to -144.68, marking a decrease of 34.41.
- For Revenue From Operations / Share (Rs.), as of Mar 20, the value is 10.63. It has decreased from 19.72 (Mar 19) to 10.63, marking a decrease of 9.09.
- For PBDIT / Share (Rs.), as of Mar 20, the value is -37.45. This value is below the healthy minimum of 2. It has increased from -38.59 (Mar 19) to -37.45, marking an increase of 1.14.
- For PBIT / Share (Rs.), as of Mar 20, the value is -42.35. This value is below the healthy minimum of 0. It has increased from -43.68 (Mar 19) to -42.35, marking an increase of 1.33.
- For PBT / Share (Rs.), as of Mar 20, the value is -42.76. This value is below the healthy minimum of 0. It has increased from -44.69 (Mar 19) to -42.76, marking an increase of 1.93.
- For Net Profit / Share (Rs.), as of Mar 20, the value is -34.46. This value is below the healthy minimum of 2. It has increased from -36.61 (Mar 19) to -34.46, marking an increase of 2.15.
- For NP After MI And SOA / Share (Rs.), as of Mar 20, the value is -34.46. This value is below the healthy minimum of 2. It has increased from -36.61 (Mar 19) to -34.46, marking an increase of 2.15.
- For PBDIT Margin (%), as of Mar 20, the value is -352.38. This value is below the healthy minimum of 10. It has decreased from -195.73 (Mar 19) to -352.38, marking a decrease of 156.65.
- For PBIT Margin (%), as of Mar 20, the value is -398.50. This value is below the healthy minimum of 10. It has decreased from -221.54 (Mar 19) to -398.50, marking a decrease of 176.96.
- For PBT Margin (%), as of Mar 20, the value is -402.34. This value is below the healthy minimum of 10. It has decreased from -226.66 (Mar 19) to -402.34, marking a decrease of 175.68.
- For Net Profit Margin (%), as of Mar 20, the value is -324.24. This value is below the healthy minimum of 5. It has decreased from -185.66 (Mar 19) to -324.24, marking a decrease of 138.58.
- For NP After MI And SOA Margin (%), as of Mar 20, the value is -324.24. This value is below the healthy minimum of 8. It has decreased from -185.67 (Mar 19) to -324.24, marking a decrease of 138.57.
- For Return on Networth / Equity (%), as of Mar 20, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 19) which recorded 0.00.
- For Return on Capital Employeed (%), as of Mar 20, the value is -10.05. This value is below the healthy minimum of 10. It has decreased from -9.71 (Mar 19) to -10.05, marking a decrease of 0.34.
- For Return On Assets (%), as of Mar 20, the value is -6.37. This value is below the healthy minimum of 5. It has increased from -6.41 (Mar 19) to -6.37, marking an increase of 0.04.
- For Long Term Debt / Equity (X), as of Mar 20, the value is -3.89. This value is below the healthy minimum of 0.2. It has increased from -5.05 (Mar 19) to -3.89, marking an increase of 1.16.
- For Total Debt / Equity (X), as of Mar 20, the value is -3.91. This value is within the healthy range. It has increased from -5.07 (Mar 19) to -3.91, marking an increase of 1.16.
- For Asset Turnover Ratio (%), as of Mar 20, the value is 0.01. It has decreased from 0.03 (Mar 19) to 0.01, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 20, the value is 2.43. This value is within the healthy range. It has decreased from 2.66 (Mar 19) to 2.43, marking a decrease of 0.23.
- For Quick Ratio (X), as of Mar 20, the value is 2.42. This value exceeds the healthy maximum of 2. It has decreased from 2.66 (Mar 19) to 2.42, marking a decrease of 0.24.
- For Inventory Turnover Ratio (X), as of Mar 20, the value is 5.98. This value is within the healthy range. It has increased from 5.87 (Mar 19) to 5.98, marking an increase of 0.11.
- For Interest Coverage Ratio (X), as of Mar 20, the value is -91.90. This value is below the healthy minimum of 3. It has decreased from -38.22 (Mar 19) to -91.90, marking a decrease of 53.68.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 20, the value is -83.56. This value is below the healthy minimum of 3. It has decreased from -35.26 (Mar 19) to -83.56, marking a decrease of 48.30.
- For Enterprise Value (Cr.), as of Mar 20, the value is 765.56. It has increased from 759.40 (Mar 19) to 765.56, marking an increase of 6.16.
- For EV / Net Operating Revenue (X), as of Mar 20, the value is 53.12. This value exceeds the healthy maximum of 3. It has increased from 28.40 (Mar 19) to 53.12, marking an increase of 24.72.
- For EV / EBITDA (X), as of Mar 20, the value is -15.07. This value is below the healthy minimum of 5. It has decreased from -14.51 (Mar 19) to -15.07, marking a decrease of 0.56.
- For MarketCap / Net Operating Revenue (X), as of Mar 20, the value is 0.09. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 19) which recorded 0.09.
- For Price / BV (X), as of Mar 20, the value is -0.01. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 19) which recorded -0.01.
- For Price / Net Operating Revenue (X), as of Mar 20, the value is 0.09. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 19) which recorded 0.09.
- For EarningsYield, as of Mar 20, the value is -35.90. This value is below the healthy minimum of 5. It has decreased from -19.07 (Mar 19) to -35.90, marking a decrease of 16.83.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alchemist Ltd:
- Net Profit Margin: -324.24%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -10.05% (Industry Average ROCE: 11.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 22.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -83.56
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.42
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 344.63)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -3.91
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -324.24%
FAQ
What is the intrinsic value of Alchemist Ltd?
Alchemist Ltd's intrinsic value (as of 20 July 2025) is 519.59 17162.13% higher the current market price of 3.01, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 4.08 Cr. market cap, FY2025-2026 high/low of /, reserves of -397 Cr, and liabilities of 422 Cr.
What is the Market Cap of Alchemist Ltd?
The Market Cap of Alchemist Ltd is 4.08 Cr..
What is the current Stock Price of Alchemist Ltd as on 20 July 2025?
The current stock price of Alchemist Ltd as on 20 July 2025 is 3.01.
What is the High / Low of Alchemist Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Alchemist Ltd stocks is ₹/.
What is the Stock P/E of Alchemist Ltd?
The Stock P/E of Alchemist Ltd is .
What is the Book Value of Alchemist Ltd?
The Book Value of Alchemist Ltd is 283.
What is the Dividend Yield of Alchemist Ltd?
The Dividend Yield of Alchemist Ltd is 0.00 %.
What is the ROCE of Alchemist Ltd?
The ROCE of Alchemist Ltd is 9.70 %.
What is the ROE of Alchemist Ltd?
The ROE of Alchemist Ltd is %.
What is the Face Value of Alchemist Ltd?
The Face Value of Alchemist Ltd is 10.0.